Trademark applications and grants for Antares Pharma Inc. Antares Pharma Inc has 22 trademark applications. The latest application filed is for "X-FACTOR"
Patent Application | Date |
---|---|
Multiple Dosage Injector with Rotating Screw Dosage System 20220203040 - 17/691809 Newton; Benjamin ;   et al. | 2022-06-30 |
Hematocrit Modulation Through Needle Assisted Jet Injection of Testosterone 20220125713 - 17/516313 Wotton; Paul K. ;   et al. | 2022-04-28 |
AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL 20220096496 - 17/494340 CHEN; Xiaoming ;   et al. | 2022-03-31 |
INJECTION DEVICE WITH CAMMED RAM ASSEMBLY 20220080131 - 17/536954 Kramer; Thomas E. ;   et al. | 2022-03-17 |
Testosterone Ester Triglyceride Formulations 20220079955 - 17/405984 Ong; Shaowei | 2022-03-17 |
NCAGE Code | 8BD12 | ANTARES PHARMA, INC. |
NCAGE Code | 0ZUN9 | ANTARES PHARMA, INC. |
CAGE Code | 0ZUN9 | ANTARES PHARMA, INC. |
CAGE Code | 8BD12 | ANTARES PHARMA, INC. |
S.A.M. Registration | 0ZUN9 [85369585] | ANTARES PHARMA, INC. |
S.A.M. Registration | 8BD12 [133621198] | ANTARES PHARMA, INC. |
DUNS | 133621198 | ANTARES PHARMA, INC. |
SEC | 0001016169 | ANTARES PHARMA, INC. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.